Medicines planning
51 results
Applied filters
National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice
4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…
Planning
We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.
Biosimilars
Regularly updated material to support the introduction of aflibercept, golimumab, ranibizumab, ustekinumab and other biosimilars of interest.
Annual medicines planning
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.
Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites
12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
New Medicines News
9 January 2026New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
The licence and supporting evidence for natalizumab biosimilar
14 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.
Good governance when implementing natalizumab biosimilar
11 December 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.
Preparing to use natalizumab biosimilar
6 February 2024Natalizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team.
Preparing to use tocilizumab biosimilar
1 August 2025Introducing biosimilar tocilizumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.